Literature DB >> 12711362

Concentration-dependent actions of glial chondroitin sulfate on the neuritic growth of midbrain neurons.

Fábio A Mendes1, Glaucia R Onofre, Luiz C F Silva, Leny A Cavalcante, José Garcia-Abreu.   

Abstract

Astrocytes located in two distinct regions of midbrain differ in their neuritic growth support abilities. Midbrain neurons cultured onto astrocyte monolayers from the lateral (L) region develop long and branched neurites while neurons cultured onto astrocyte monolayers from the medial (M) region develop short or no neurites. The extracellular matrix of these astrocytes has an important role in promoting or inhibiting the growth of these neurons. Differences on the compartmental distribution, as well as on the concentration of GAGs of L and M astrocytes, may be related to their differential capacity of supporting neuritic growth. Indeed, enzymatic digestion of heparan sulfate (HS) and chondroitin sulfate (CS) chains also pointed to an important function for GAGs on axon navigation. In order to better characterize the role of CS on the growth of midbrain neurites, we treated L and M astrocyte monolayers with 1 mM of beta-D-xyloside. Under these conditions, astrocytes oversynthesized and secreted CS protein-free chains to the culture medium. M astrocytes had a significant reduction in their neuritic growth-inhibiting ability after xyloside treatment, suggesting a promoting role for soluble CS in neuritic growth. Chondroitin 4-sulfate (CS-4) added in different concentrations to M astrocyte cultures turned this glia into a permissive substrate, acting in a linear way as far as the largest neurite was concerned. However, a U-shaped dose-effect curve on neurite growth resulted from the similar treatment of L astrocytes. These results suggest that glial CS-4 could be involved in the neurite growth modulating properties of midbrain neurons in a complex concentration-dependent way.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711362     DOI: 10.1016/s0165-3806(03)00036-1

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  6 in total

Review 1.  Neuron-astroglial interactions in cell-fate commitment and maturation in the central nervous system.

Authors:  Joice Stipursky; Tânia Cristina Leite de Sampaio E Spohr; Vivian Oliveira Sousa; Flávia Carvalho Alcantara Gomes
Journal:  Neurochem Res       Date:  2012-05-22       Impact factor: 3.996

2.  Biologic scaffolds composed of central nervous system extracellular matrix.

Authors:  Peter M Crapo; Christopher J Medberry; Janet E Reing; Stephen Tottey; Yolandi van der Merwe; Kristen E Jones; Stephen F Badylak
Journal:  Biomaterials       Date:  2012-02-14       Impact factor: 12.479

3.  Azide-Functionalized Naphthoxyloside as a Tool for Glycosaminoglycan Investigations.

Authors:  Daniel Willén; Roberto Mastio; Zackarias Söderlund; Sophie Manner; Gunilla Westergren-Thorsson; Emil Tykesson; Ulf Ellervik
Journal:  Bioconjug Chem       Date:  2021-11-16       Impact factor: 4.774

4.  Connective tissue growth factor (CTGF/CCN2) is negatively regulated during neuron-glioblastoma interaction.

Authors:  Luciana F Romão; Fabio A Mendes; Natalia M Feitosa; Jane Cristina O Faria; Juliana M Coelho-Aguiar; Jorge Marcondes de Souza; Vivaldo Moura Neto; José Garcia Abreu
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

5.  Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation.

Authors:  Asya Rolls; Ravid Shechter; Anat London; Yifat Segev; Jasmin Jacob-Hirsch; Ninette Amariglio; Gidon Rechavi; Michal Schwartz
Journal:  PLoS Med       Date:  2008-08-19       Impact factor: 11.069

6.  Connective-Tissue Growth Factor (CTGF/CCN2) Induces Astrogenesis and Fibronectin Expression of Embryonic Neural Cells In Vitro.

Authors:  Fabio A Mendes; Juliana M Coelho Aguiar; Suzana A Kahn; Alice H Reis; Luiz Gustavo Dubois; Luciana Ferreira Romão; Lais S S Ferreira; Hervé Chneiweiss; Vivaldo Moura Neto; José G Abreu
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.